These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8649766)

  • 1. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
    Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
    Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53.
    Kraus E; Strong LC; Tainsky MA
    Gene; 1998 May; 211(2):229-34. PubMed ID: 9602136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants.
    Maclean K; Rogan EM; Whitaker NJ; Chang AC; Rowe PB; Dalla-Pozza L; Symonds G; Reddel RR
    Oncogene; 1994 Mar; 9(3):719-25. PubMed ID: 8108114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
    Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.
    Ford JM; Hanawalt PC
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8876-80. PubMed ID: 7568035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UV-induced mutations of supF gene on a shuttle vector plasmid in p53-deficient mouse cells are qualitatively different from those in wild-type cells.
    Ishizaki K; Nishizawa K; Mimaki S; Aizawa S
    Mutat Res; 1996 Sep; 364(1):43-9. PubMed ID: 8814337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts.
    Gollahon LS; Kraus E; Wu TA; Yim SO; Strong LC; Shay JW; Tainsky MA
    Oncogene; 1998 Aug; 17(6):709-17. PubMed ID: 9715272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinds and spectrum of mutations induced by 1-nitrosopyrene adducts during plasmid replication in human cells.
    Yang JL; Maher VM; McCormick JJ
    Mol Cell Biol; 1988 Aug; 8(8):3364-72. PubMed ID: 3062380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.
    Yin Y; Tainsky MA; Bischoff FZ; Strong LC; Wahl GM
    Cell; 1992 Sep; 70(6):937-48. PubMed ID: 1525830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
    Gu J; Kawai H; Wiederschain D; Yuan ZM
    Cancer Res; 2001 Feb; 61(4):1741-6. PubMed ID: 11245491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended lifespan and immortalization of human fibroblasts induced by X-ray irradiation.
    Tsutsui T; Tanaka Y; Matsudo Y; Hasegawa K; Fujino T; Kodama S; Barrett JC
    Mol Carcinog; 1997 Jan; 18(1):7-18. PubMed ID: 9022808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 germline mutations in Li-Fraumeni syndrome.
    Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
    Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.
    Buzby JS; Williams SA; Schaffer L; Head SR; Nugent DJ
    Cancer Genet; 2017 Feb; 211():9-17. PubMed ID: 28279309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?
    Williams KJ; Boyle JM; Birch JM; Norton JD; Scott D
    Oncogene; 1997 Jan; 14(3):277-82. PubMed ID: 9018113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
    Stolzenberg MC; Brugières L; Gardes M; Dessarps-Freichey F; Chompret A; Bressac B; Lenoir G; Bonaïti-Pellié C; Lemerle J; Feunteun J
    Oncogene; 1994 Oct; 9(10):2799-804. PubMed ID: 8084585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube.
    Xian W; Miron A; Roh M; Semmel DR; Yassin Y; Garber J; Oliva E; Goodman A; Mehra K; Berkowitz RS; Crum CP; Quade BJ
    J Pathol; 2010 Jan; 220(1):17-23. PubMed ID: 19834951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-N-nitrosourea-induced mutations in a shuttle plasmid replicated in human cells.
    Sikpi MO; Waters LC; Kraemer KH; Preston RJ; Mitra S
    Mol Carcinog; 1990; 3(1):30-6. PubMed ID: 2157457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.